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anaging  a  difﬁcult  ethical  and  legal  equilibrium
n healthcare:  Assuring  access  to the  basics  while
eeping up  with  innovation gestão  de  um  difícil  equilíbrio  ético-legal  em  saúde:  assegurar  o
cesso  aos  cuidados  básicos  mantendo  a  inovac¸ãohere is a new and challenging paradigm in healthcare which
s pervading the sector and contains an apparent internal con-
ict. On one side, the fundamental human right of access to
asic healthcare, (see article 25 of the Universal Declaration
f Human Rights – UDHR1 and article 12 of the International
ovenant on Economic, Social and Cultural Rights – ICESCR2)
eems to become more  and more  difﬁcult to attain in most
arts of the world, including the so-called Western developed
ountries where a ﬁnancial crisis, which started in 2008, is
1 Article 25 of the UDHR
.  Everyone has the right to a standard of living adequate for the
ealth and well-being of himself and of his family, including food,
lothing, housing and medical care and necessary social services,
nd the right to security in the event of unemployment, sickness,
isability, widowhood, old age or other lack of livelihood in cir-
umstances beyond his control.
.  Motherhood and childhood are entitled to special care and assis-
ance. All children, whether born in or out of wedlock, shall enjoy
he  same social protection.
2 Article 12 of the ICESCR
.  The States Parties to the present Covenant recognize the right
f  everyone to the enjoyment of the highest attainable standard of
hysical and mental health.
. The steps to be taken by the States Parties to the present
ovenant to achieve the full realization of this right shall include
hose necessary for:
a) The provision for the reduction of the stillbirth-rate and of
nfant mortality and for the healthy development of the child;
b)  The improvement of all aspects of environmental and industrial
ygiene;
c)  The prevention, treatment and control of epidemic, endemic,
ccupational and other diseases;
d)  The creation of conditions which would assure to all medical
ervice and medical attention in the event of sickness.yet to be completely resolved. On the other side, the most
advanced and expensive biomedical technologies applied to
prevention, diagnosis and treatment continue to expand in
very sophisticated ways and the right to enjoy the beneﬁts
of such scientiﬁc progress is also coined as a fundamen-
tal human right (see article 27 of the UDHR3 and article 15
of the ICESCR4). This tension between investing in granting
immediate access to basic healthcare when resources are
lacking and developing novel solutions that can only bene-
ﬁt a few in the short-term but promise to offer widespread
progress later, requires rational and reﬂexive analysis in order
3 Article 27 of the UDHR
1.  Everyone has the right to freely participate in the cultural life of
the  community, to enjoy the arts and to share in scientiﬁc advance-
ment and its beneﬁts.
2. Everyone has the right to the protection of the moral and
material interests resulting from any scientiﬁc, literary or artistic
production of which he is the author.
4 Article 15 of the ICESCR
1.  The States Parties to the present Covenant recognize the right
of  everyone:
(a) To take part in cultural life;
(b) To enjoy the beneﬁts of scientiﬁc progress and its applications;
(c)  To beneﬁt from the protection of the moral  and material inter-
ests  resulting from any scientiﬁc, literary or artistic production of
which he is the author.
2.  Shall take the steps necessary for the conservation, the devel-
opment and the diffusion of science and culture.
3. Undertake to respect the freedom indispensable for scientiﬁc
research and creative activity.
4. Recognize the beneﬁts to be derived from the encouragement
and development of international contacts and co-operation in
the scientiﬁc and cultural ﬁelds.
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to strike the right balance and prioritization. Innovation is
indeed fundamental and therefore the funding and the cre-
ation of incentives to public and private research cannot be
neglected, otherwise the novelty in healthcare can stagnate
and with it the endless possibilities to continue to efﬁciently
minimize human suffering. That outcome is undesirable even
to those who are most critical of the way healthcare research
and innovation are currently designed, ﬁnanced and executed,
particularly concerning well documented unethical practices.
In reality, the investment in innovative leading edge
healthcare technology can also contribute to the realiza-
tion of the right to access healthcare by improving the
accuracy and as such also the efﬁciency of healthcare mea-
sures. This investment should proceed in tandem with the
application of current know-how to bring healthcare to the
regions of the world where it is currently inaccessible and
where human suffering demands urgent amelioration. There-
fore, a rational system must understand that investing in
the future, for example in the form of genomic technolo-
gies aimed at achieving effective personalized medicine,
does not have to collide or fall under the immediate
premise that every human life deserves the highest attain-
able state of health at the present time. Nevertheless,
the required trade-offs to perfect such system are nec-
essarily difﬁcult to ﬁnd and require permanent scrutiny
and multidisciplinary evaluation, which includes neces-
sary inputs from economics, medicine, science, law and
ethics.
This issue of the Portuguese Review of Public Health
presents original articles that look at these two conﬂicting
realities, i.e. the difﬁculty of rationing healthcare and the
necessity of maintaining a steady pace of innovation, through
the lens of human rights, ethics and health law. The result may
be a somewhat “bipolar” picture, where we  simultaneously
strive to search for solutions to the lack of essential healthcare
– for example by providing the best legal and ethical answers
to tackle inequity in health systems – and on the other side,
continue to meet the legal and ethical challenges brought by . 2 0 1 4;3 2(2):121–122
the advances of biomedical science, such as the breach of the
rights to privacy and medical conﬁdentiality.
The same philosophy encompasses the ongoing societal
efforts to implement measures that can expand access to
healthcare in more  affordable ways (v.g. generics) and also to
promote measures and interventions to help the most vul-
nerable (v.g. the elderly) to better manage and improve their
health.
The analysis provided by the articles included in this RPSP
issue will certainly contribute to the discussion introduced
above. However, it will not offer any decisive or ﬁnal solutions
to such a complex range of topics. Nonetheless, one idea that
sounds more  like an impasse than a conclusion becomes clear:
basic healthcare is a priority but the continuity of the invest-
ment in patient safety, health promotion and innovation in
health cannot be jeopardized under the economic pressure.
This equilibrium is indeed difﬁcult and almost impossible
to manage, but no part of it should completely overshadow
the other. To our assurance, while trying to deal with the
most intricate issues that confront our societies, the best
practices often result from the tension between different
and sometimes conﬂicting perspectives and their respective
convictions. Hopefully, that will also be the case with the real-
ization of the fundamental human rights discussed above: the
right to access timely, acceptable, and affordable health care
of appropriate quality and the right to enjoy the beneﬁts of
scientiﬁc progress and its applications.
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